EMEA-000245-PIP01-08-M06
Key facts
Invented name |
Amitiza
|
Active substance |
Lubiprostone
|
Therapeutic area |
Gastroentology-Hepatology
|
Decision number |
P/0363/2019
|
PIP number |
EMEA-000245-PIP01-08-M06
|
Pharmaceutical form(s) |
Capsule, soft
|
Condition(s) / indication(s) |
Treatment of constipation
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Sucampo AG
E-mail: medinfo@mnk.com |
Decision type |
PM: decision on the application for modification of an agreed PIP
|
Compliance procedure number |
EMEA-C-000245-PIP01-08-M06
|
Compliance opinion date |
28/02/2020
|
Compliance outcome |
positive
|